Medical News

RSS

HCPRA seeks entries for Hollobon Award

The Health Care Public Relations Association (HCPRA) is pleased to announce this year's Call for Entries for The Hollobon Award.

9 Feb 2010

U.S. PSA screening efficacy lower than in ERSPC-Rotterdam due to lower testing sensitivity

Fewer prostate cancers were detected by prostate-specific antigen (PSA) screening in the U.S. than in a European randomized trial because of lower screening sensitivity, according to a new brief communication published online February 8 in the Journal of the National Cancer Institute.

9 Feb 2010

Lundbeck launches web-based initiative to support people with rare diseases

In support of Rare Disease Day 2010, set for February 28, Lundbeck Inc. today launched the Raise Your Hand to Fight Rare Diseases campaign. The web-based initiative is designed to generate support for people with rare diseases and is being conducted in partnership with the National Organization for Rare Disorders (NORD), the sponsor of Rare Disease Day in the United States.

9 Feb 2010

Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinson’s disease biomarker

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has been awarded a grant of $304,000 from The Michael J. Fox Foundation for Parkinson's Research (MJFF). The grant is to fund a project entitled: “Development of an alpha6*-selective Neuronal Nicotinic Receptor (NNR) Imaging Agent as a Parkinson’s Disease Biomarker” and is the second awarded to Targacept by MJFF in the last six months.

9 Feb 2010

Racial disparities continue in U.S. cancer screening practices

The incidence of advanced breast cancer diagnosis among black women remained 30 percent to 90 percent higher compared to white women between 1992 and 2004, according to new findings by researchers at Fred Hutchinson Cancer Research Center. In addition, the disparity in the incidence of advance colorectal cancer actually widened over this time period as rates fell among whites but increased slightly among blacks.

9 Feb 2010

Italian researchers identify a new therapeutic approach for Ewing sarcoma

Ewing sarcoma (EWS) is a bone tumor of unknown cellular origin that affects children and young adults. The protein CD99 is highly expressed in most cases of EWS, but its function in the disease is unknown.

9 Feb 2010

Synta Pharmaceuticals' STA-9090 inhibits WT1 protein in AML

Synta Pharmaceuticals Corp. today announced that preclinical results presented at the “Bridging the Gap 2010” Hematologic Conference, held in Singapore City, Singapore, February 5-7, 2010, shows that STA-9090, a potent inhibitor of heat shock protein 90 (Hsp90), inhibits the Wilms’ tumor 1 (WT1) protein, a key transcription factor that drives disease progression in acute myeloid leukemia (AML) as well as certain other leukemias. STA-9090 is currently enrolling patients in two clinical trials in AML and other hematologic cancers.

9 Feb 2010

NPSF leads nationwide effort to strengthen partnerships between patients and healthcare providers

The National Patient Safety Foundation (NPSF) will kick off Patient Safety Awareness Week on March 7, 2010, in a concerted effort to raise awareness of patient safety initiatives, improve the quality of health care, and strengthen alliances between patients, families and their healthcare providers.

9 Feb 2010

Sanofi-aventis completes tender offer for Chattem common stock

Sanofi-aventis announced today that it has successfully completed its tender offer for all outstanding shares of common stock of Chattem, Inc..

9 Feb 2010

Vigilan announces new continuing education courses for assisted living community administrators

Vigilan, provider of software for better senior living, announced today 10 new continuing education courses for assisted living community administrators. These courses—developed and taught by Christian Mason, chairman and CEO of Vigilan, nationally certified leader in assisted living training, and developer of the first national licensing exam—are certified for assisted living administrator licensing in 16 states.

9 Feb 2010

Cedars-Sinai Medical Center receives $300,000 grant for program delivering healthcare to underserved children

Cedars-Sinai Medical Center announced a $300,000 grant from OneWest Foundation to support the Community Outreach Assistance for Children’s Health (COACH) program. The grant will fund the delivery of free, high-quality healthcare in a mobile medical clinic that reaches out to underserved children and their families in Los Angeles.

9 Feb 2010

Findings point towards new therapeutic approach for breast and prostate cancer

In a new approach to developing treatments for breast cancer, prostate cancer and enlarged hearts, Loyola University Stritch School of Medicine researchers are zeroing in on a workhorse protein called RSK.

9 Feb 2010

Cell Therapeutics' pixantrone NDA: FDA postpones ODAC meeting due to severe weather conditions

Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that the United States Food and Drug Administration informed CTI that due to severe weather conditions in the Washington, D.C. area, the FDA is postponing the Oncologic Drugs Advisory Committee ("ODAC") meeting that was to be held on Wednesday, February 10, 2010 to discuss the pixantrone New Drug Application ("NDA"). The FDA indicated that it intends to reschedule the meeting as soon as the FDA can determine a schedule that will allow them to reconvene the advisory panel.

9 Feb 2010

Three in ten overweight teenagers think they are underweight

Three in ten overweight teens believe they are actually underweight or "about right," according to a study of more than 65,000 high school students.

9 Feb 2010

Scientists identify enzyme mutations in AML patients

A study published online on February 8 in the Journal of Experimental Medicine (www.jem.org) reports that several distinct mutations found in a subset of patients with acute myelogenous leukemia (AML) result in excess production of the same metabolite.

9 Feb 2010

Merck's asthma drug formoterol/mometasone to garner global peak year sales of more than $250M

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, following its expected launch this year for the treatment of asthma, Merck's formoterol/mometasone will garner peak year sales of more than $250 million in the United States, France, Germany, Italy, Spain and the United Kingdom.

9 Feb 2010

Mediterranean diet can avoid brain infarcts, reduce risk of Alzheimer's disease

A Mediterranean diet may help people avoid the small areas of brain damage that can lead to problems with thinking and memory, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

9 Feb 2010

USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza

NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.

9 Feb 2010

KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer’s disease

KineMed, Inc. a translational and personalized medicine development company, today announced a broadening of its collaboration with Bristol-Myers Squibb Company (NYSE: BMY) in the area of Alzheimer’s disease and other neurodegenerative conditions.

9 Feb 2010

PM vows to provide better preventive care for cancer patients

The prime minister has pledged to introduce one-to-one support at home for all cancer patients if the government stays in power after the forthcoming general election.

9 Feb 2010

Medical News

HCPRA seeks entries for Hollobon Award

U.S. PSA screening efficacy lower than in ERSPC-Rotterdam due to lower testing sensitivity

Lundbeck launches web-based initiative to support people with rare diseases

Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinson’s disease biomarker

Racial disparities continue in U.S. cancer screening practices

Italian researchers identify a new therapeutic approach for Ewing sarcoma

Synta Pharmaceuticals' STA-9090 inhibits WT1 protein in AML

NPSF leads nationwide effort to strengthen partnerships between patients and healthcare providers

Sanofi-aventis completes tender offer for Chattem common stock

Vigilan announces new continuing education courses for assisted living community administrators

Cedars-Sinai Medical Center receives $300,000 grant for program delivering healthcare to underserved children

Findings point towards new therapeutic approach for breast and prostate cancer

Cell Therapeutics' pixantrone NDA: FDA postpones ODAC meeting due to severe weather conditions

Three in ten overweight teenagers think they are underweight

Scientists identify enzyme mutations in AML patients

Merck's asthma drug formoterol/mometasone to garner global peak year sales of more than $250M

Mediterranean diet can avoid brain infarcts, reduce risk of Alzheimer's disease

USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza

KineMed, Bristol-Myers Squibb broaden collaboration to develop novel mechanisms for Alzheimer’s disease

PM vows to provide better preventive care for cancer patients

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News